Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ATR
ATR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATR News
AptarGroup Reports Strong Q4 2025 Earnings with Strategic Insights
Feb 06 2026
seekingalpha
AptarGroup Reports Decline in Q4 Profit
Feb 06 2026
NASDAQ.COM
AptarGroup Q4 Earnings Exceed Expectations
Feb 05 2026
seekingalpha
AptarGroup to Announce Q4 Earnings on February 5th
Feb 04 2026
seekingalpha
Aptar Achieves Prestigious 'A' Score on CDP Climate Change Assessment for Second Year
Jan 21 2026
Yahoo Finance
AptarGroup Supports CastleVax's Phase II Clinical Trial of COVID-19 Vaccine with Innovative Delivery Solutions
Jan 13 2026
Businesswire
AptarGroup Schedules 2026 Quarterly Conference Call Dates
Jan 07 2026
Businesswire
Aptar Announces 2026 Quarterly Conference Call Schedule
Jan 07 2026
Newsfilter
Ave Maria Growth Fund Reports -0.48% Q3 Return, Underperforming S&P 500
Jan 07 2026
Yahoo Finance
Aptar Partners with ŌURA to Integrate Migraine Buddy with Oura Ring
Jan 06 2026
Businesswire
Aptar Partners with ŌURA to Enhance Migraine Insights via Migraine Buddy Integration
Jan 06 2026
Newsfilter
AptarGroup to Participate in 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Jan 05 2026
Businesswire
Aptar Launches CARDAMYST Nasal Spray to Address Needs of 2 Million PSVT Patients
Dec 17 2025
Businesswire
Aptar Launches CARDAMYST Nasal Spray for PSVT Treatment
Dec 17 2025
Newsfilter
Stock to Watch: AptarGroup (ATR) Declared Bear of the Day
Dec 09 2025
NASDAQ.COM
AptarGroup Named One of America's Most Responsible Companies 2026 for Seventh Year
Dec 04 2025
Businesswire
Show More News
